Skip to main content

Table 4 Comparison of circulating cytokines in MIS-C patients

From: Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study

Cytokines, fold difference [Q1, Q3]

All MIS-C

IVIG monotherapy

All IVIG + anakinra

p-value

IFNγ

1.0 [0.4–1.6]

0.4 [0.40–1.2]

1.0 [0.5–2.1]

0.07

IL-1β

0.9 [0.2–1.0]

0.9 [0.7–0.9]

0.9 [0.2–1.0]

0.37

IL-2

1.0 [1.0–1.0]

1.0 [1.0–1.0]

1.0 [1.0–1.0]

0.74

IL-6

14.3 [3.2–34.4]

3.0 [1.6–15.8]

22.1 [9.9–39.0]

0.006

IL-8

0.6 [0.3–1.0]

0.3 [0.3–0.6]

1.0 [0.3–1.0]

0.03

IL-12

0.4 [0.4–1.0]

0.4 [0.4–0.4]

0.7 [0.4–1.0]

0.10

IL-17

1.0 [0.6–1.6]

1.0 [0.6–3.0]

1.0 [0.6–1.0]

0.98

sIL-2R

4.0 [2.0–6.7]

1.4 [0.9–3.2]

5.7 [3.7–7.8]

0.0006

TNFα

0.3 [0.1–0.5]

0.2 [0.1–0.3]

0.3 [0.2–0.6]

0.11